TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010
TCL Archive NIH Reauthorization Compromise Between House and Senate Gives NCI Three Year Authorization Period October 18, 1985
TCL Archive Talking Back: FDA Faces Challenges Over Avastin & Prostate Cancer Prevention January 21, 2011